CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Nat Rev Immunol. 2021 Feb;21(2):73-82. doi: 10.1038/s41577-020-00480-0. Epub 2020 Dec 18.
Vaccines are urgently needed to control the coronavirus disease 2019 (COVID-19) pandemic and to help the return to pre-pandemic normalcy. A great many vaccine candidates are being developed, several of which have completed late-stage clinical trials and are reporting positive results. In this Progress article, we discuss which viral elements are used in COVID-19 vaccine candidates, why they might act as good targets for the immune system and the implications for protective immunity.
疫苗是控制 2019 年冠状病毒病(COVID-19)大流行和帮助恢复大流行前常态的迫切需要。正在开发大量疫苗候选物,其中一些已经完成了后期临床试验并报告了积极结果。在这篇进展文章中,我们讨论了 COVID-19 疫苗候选物中使用的哪些病毒成分,为什么它们可能成为免疫系统的良好靶标,以及对保护性免疫的影响。